4//SEC Filing
RICHMAN ERIC I 4
Accession 0001104659-22-031172
CIK 0001173281other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 7:13 PM ET
Size
9.9 KB
Accession
0001104659-22-031172
Insider Transaction Report
Form 4
RICHMAN ERIC I
Director
Transactions
- Purchase
Common stock
2022-03-01$1.58/sh+1,580$2,496→ 42,660 total - Purchase
Common stock
2022-03-03$1.72/sh+1,300$2,236→ 43,960 total - Purchase
Common stock
2022-03-04$1.62/sh+1,000$1,620→ 44,960 total
Holdings
- 27,747(indirect: See footnote)
Common stock
Footnotes (4)
- [F1]The power of attorney under which this form was signed is on file with the Commission.
- [F2]Shares are held in a trust for the benefit of the Reporting Person with the Reporting Person and the Reporting Person's spouse serving as co-trustees.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]These shares were purchased in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased in at each separate transaction.
Documents
Issuer
NeuBase Therapeutics, Inc.
CIK 0001173281
Entity typeother
Related Parties
1- filerCIK 0001313876
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 7:13 PM ET
- Size
- 9.9 KB